Bayesian Phylogenetic Models Research Articles

Phylogenetic study of Gymnodinium dorsalisulcum comb. nov. from tropical Australian coastal waters (Dinophyceae)

SUMMARYA new species of the dinoflagellate genus Gymnodinium Stein, previously considered a member of Katodinium Fott, is characterized from two marine benthic habitats in tropical northern Australia. Gymnodinium dorsalisulcum comb. nov. was found to be very abundant at times, and in culture produced large quantities of mucus. We analyzed two regions of ribosomal DNA from this species (partial large subunit and complete small subunit sequences), using Bayesian analysis and phylogenetic models appropriate to alignments of ribosomal RNA genes. We compared it to eight species of the ‘true’Gymnodinium clade and to other dinoflagellates. The results show that it is a member of the Gymnodinium clade, and is closely related to Gymnodinium impudicum and G. chlorophorum. Katodinium was originally defined as having cells with an epitheca that is much larger than the hypotheca. However, this character is clearly inadequate, and the genus requires a re‐investigation to determine the apomorphies of the type species.

Continued Evolution in gp41 after Interruption of Enfuvirtide in Subjects with Advanced HIV Type 1 Disease

Careful examination of viral dynamics during antiretroviral treatment can provide important insights into HIV pathogenesis. We examined viral evolution during and after enfuvirtide (T-20) treatment with an objective of defining the characteristics of viral evolution during advanced HIV immunodeficiency. Specifically, we examined the viral quasispecies from nine patients who experienced incomplete viral suppression on an enfuvirtide-based regimen, and who subsequently interrupted enfuvirtide while remaining on a stable optimized background regimen (enfuvirtide "partial treatment interruption"). On average, eight clones were sequenced from three time points: pre-enfuvirtide, post-enfuvirtide failure, and post-enfuvirtide interruption. We utilized a Bayesian hierarchical phylogenetic model to assess the evolutionary relatedness of the virus that emerged over time. In most subjects, interruption of enfuvirtide was associated with continued viral evolution as enfuvirtide mutations waned; in no subject did we find clear evidence supporting the reemergence of archived wild-type variants (Bayes factor=30.2, p=0.01). Evidence supporting ongoing viral evolution was particularly strong in subjects whose virus remained diverse or became more diverse during enfuvirtide therapy. In contrast to observations when all drugs are interrupted, loss of resistance during enfuvirtide interruption is most likely due to ongoing viral evolution (and back-mutation), rather than emergence of an archived virus.